Dosimetric comparison of hippocampal-sparing technologies in patients with low-grade glioma

Dosimetric comparison of hippocampal-sparing technologies in patients with low-grade glioma

Abstract Background Radiotherapy (RT) plays an integral role in the management of low-grade gliomas (LGG). Late toxicity from RT can cause progressive neurocognitive dysfunction. Radiation-induced damage to the hippocampus (HCP) plays a considerable role in memory decline. Advancements in photon pla...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Neuro-oncology advances 2024-01, Vol.6 (1), p.vdae131
Hauptverfasser: Williamson, Aoife, Houston, Peter, Paterson, Jennifer, Chalmers, Anthony J, McLoone, Philip, Fullerton, Natasha, Foo, Sin Yee, James, Allan, Nowicki, Stefan
Format: Artikel
Sprache:eng
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue 1
container_start_page vdae131
container_title Neuro-oncology advances
container_volume 6
creator Williamson, Aoife
Houston, Peter
Paterson, Jennifer
Chalmers, Anthony J
McLoone, Philip
Fullerton, Natasha
Foo, Sin Yee
James, Allan
Nowicki, Stefan
description Abstract Background Radiotherapy (RT) plays an integral role in the management of low-grade gliomas (LGG). Late toxicity from RT can cause progressive neurocognitive dysfunction. Radiation-induced damage to the hippocampus (HCP) plays a considerable role in memory decline. Advancements in photon planning software have resulted in the development of multi-criteria optimization (MCO) and HyperArc technologies which may improve HCP sparing while maintaining planning target volume (PTV) target coverage. Methods Three planning methods for hippocampal sparing (HS) were compared, volumetric modulated arc therapy (VMAT) without HS (VMAT_noHS), VMAT with HS (VMAT_HS), MCO with HS (MCO_HS), and HyperArc with HS (HyperArc_HS). Results Twenty-five patients were identified. The contralateral HCP was spared in 16 patients and bilateral HCP in 9 patients with superiorly located tumors. All 3 HS planning techniques showed significant reductions in dose to the spared HCP in contralateral cases but only VMAT_HS and MCO_HS achieved this in bilateral cases (P 
doi_str_mv 10.1093/noajnl/vdae131
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_3099856679</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><oup_id>10.1093/noajnl/vdae131</oup_id><sourcerecordid>3099856679</sourcerecordid><originalsourceid>FETCH-LOGICAL-c254t-dfa04ab28356521d116968a3bf3d4064a62a7b719ec10018631fc2647eaf0a443</originalsourceid><addsrcrecordid>eNqFkD1PwzAQhi0EolXpyog8wpDWX3GTEZVPqRILTAzRxXFSV44d4oSKf0-qFMTGdKdXz706PQhdUrKgJOVL52Hn7PKzAE05PUFTJjmLmEiT0z_7BM1D2BFCWCxiQdg5mvCUMcKEmKL3Ox9MrbvWKKx83UBrgnfYl3hrmsYrGCIbhUPuKtxptXXe-srogI3DDXRGuy7gvem22Pp9VLVQaFxZ42u4QGcl2KDnxzlDbw_3r-unaPPy-Ly-3URq-KiLihKIgJwlPJYxowWlMpUJ8LzkhSBSgGSwylc01YoSQhPJaamYFCsNJQEh-Axdj71N6z96HbqsNkFpa8Fp34eMkzRNYilX6YAuRlS1PoRWl1nTmhrar4yS7OA0G51mR6fDwdWxu89rXfziPwYH4GYEfN_8V_YNsTeDdw</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>3099856679</pqid></control><display><type>article</type><title>Dosimetric comparison of hippocampal-sparing technologies in patients with low-grade glioma</title><source>DOAJ Directory of Open Access Journals</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>Oxford Journals Open Access Collection</source><source>PubMed Central</source><creator>Williamson, Aoife ; Houston, Peter ; Paterson, Jennifer ; Chalmers, Anthony J ; McLoone, Philip ; Fullerton, Natasha ; Foo, Sin Yee ; James, Allan ; Nowicki, Stefan</creator><creatorcontrib>Williamson, Aoife ; Houston, Peter ; Paterson, Jennifer ; Chalmers, Anthony J ; McLoone, Philip ; Fullerton, Natasha ; Foo, Sin Yee ; James, Allan ; Nowicki, Stefan</creatorcontrib><description>Abstract Background Radiotherapy (RT) plays an integral role in the management of low-grade gliomas (LGG). Late toxicity from RT can cause progressive neurocognitive dysfunction. Radiation-induced damage to the hippocampus (HCP) plays a considerable role in memory decline. Advancements in photon planning software have resulted in the development of multi-criteria optimization (MCO) and HyperArc technologies which may improve HCP sparing while maintaining planning target volume (PTV) target coverage. Methods Three planning methods for hippocampal sparing (HS) were compared, volumetric modulated arc therapy (VMAT) without HS (VMAT_noHS), VMAT with HS (VMAT_HS), MCO with HS (MCO_HS), and HyperArc with HS (HyperArc_HS). Results Twenty-five patients were identified. The contralateral HCP was spared in 16 patients and bilateral HCP in 9 patients with superiorly located tumors. All 3 HS planning techniques showed significant reductions in dose to the spared HCP in contralateral cases but only VMAT_HS and MCO_HS achieved this in bilateral cases (P &lt; .008). Only MCO_HS was superior to VMAT_HS in lowering the dose to both contralateral HCP and bilateral HCP in all measured metrics (P &lt; .008). PTV and OAR (organ at risk) dose constraints were achieved for all plans. Conclusions This retrospective dosimetric study demonstrated the feasibility of HS for low-grade glioma. All 3 HS planning techniques achieved significant dose reductions to the spared contralateral hippocampus, but only MCO_HS and VMAT_HS achieved this in bilateral cases. MCO was superior to other planning techniques for sparing both bilateral and contralateral hippocampi.</description><identifier>ISSN: 2632-2498</identifier><identifier>EISSN: 2632-2498</identifier><identifier>DOI: 10.1093/noajnl/vdae131</identifier><identifier>PMID: 39220244</identifier><language>eng</language><publisher>US: Oxford University Press</publisher><ispartof>Neuro-oncology advances, 2024-01, Vol.6 (1), p.vdae131</ispartof><rights>The Author(s) 2024. Published by Oxford University Press, the Society for Neuro-Oncology and the European Association of Neuro-Oncology. 2024</rights><rights>The Author(s) 2024. Published by Oxford University Press, the Society for Neuro-Oncology and the European Association of Neuro-Oncology.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c254t-dfa04ab28356521d116968a3bf3d4064a62a7b719ec10018631fc2647eaf0a443</cites><orcidid>0009-0007-7443-6658</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,864,1604,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/39220244$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Williamson, Aoife</creatorcontrib><creatorcontrib>Houston, Peter</creatorcontrib><creatorcontrib>Paterson, Jennifer</creatorcontrib><creatorcontrib>Chalmers, Anthony J</creatorcontrib><creatorcontrib>McLoone, Philip</creatorcontrib><creatorcontrib>Fullerton, Natasha</creatorcontrib><creatorcontrib>Foo, Sin Yee</creatorcontrib><creatorcontrib>James, Allan</creatorcontrib><creatorcontrib>Nowicki, Stefan</creatorcontrib><title>Dosimetric comparison of hippocampal-sparing technologies in patients with low-grade glioma</title><title>Neuro-oncology advances</title><addtitle>Neurooncol Adv</addtitle><description>Abstract Background Radiotherapy (RT) plays an integral role in the management of low-grade gliomas (LGG). Late toxicity from RT can cause progressive neurocognitive dysfunction. Radiation-induced damage to the hippocampus (HCP) plays a considerable role in memory decline. Advancements in photon planning software have resulted in the development of multi-criteria optimization (MCO) and HyperArc technologies which may improve HCP sparing while maintaining planning target volume (PTV) target coverage. Methods Three planning methods for hippocampal sparing (HS) were compared, volumetric modulated arc therapy (VMAT) without HS (VMAT_noHS), VMAT with HS (VMAT_HS), MCO with HS (MCO_HS), and HyperArc with HS (HyperArc_HS). Results Twenty-five patients were identified. The contralateral HCP was spared in 16 patients and bilateral HCP in 9 patients with superiorly located tumors. All 3 HS planning techniques showed significant reductions in dose to the spared HCP in contralateral cases but only VMAT_HS and MCO_HS achieved this in bilateral cases (P &lt; .008). Only MCO_HS was superior to VMAT_HS in lowering the dose to both contralateral HCP and bilateral HCP in all measured metrics (P &lt; .008). PTV and OAR (organ at risk) dose constraints were achieved for all plans. Conclusions This retrospective dosimetric study demonstrated the feasibility of HS for low-grade glioma. All 3 HS planning techniques achieved significant dose reductions to the spared contralateral hippocampus, but only MCO_HS and VMAT_HS achieved this in bilateral cases. MCO was superior to other planning techniques for sparing both bilateral and contralateral hippocampi.</description><issn>2632-2498</issn><issn>2632-2498</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><sourceid>TOX</sourceid><recordid>eNqFkD1PwzAQhi0EolXpyog8wpDWX3GTEZVPqRILTAzRxXFSV44d4oSKf0-qFMTGdKdXz706PQhdUrKgJOVL52Hn7PKzAE05PUFTJjmLmEiT0z_7BM1D2BFCWCxiQdg5mvCUMcKEmKL3Ox9MrbvWKKx83UBrgnfYl3hrmsYrGCIbhUPuKtxptXXe-srogI3DDXRGuy7gvem22Pp9VLVQaFxZ42u4QGcl2KDnxzlDbw_3r-unaPPy-Ly-3URq-KiLihKIgJwlPJYxowWlMpUJ8LzkhSBSgGSwylc01YoSQhPJaamYFCsNJQEh-Axdj71N6z96HbqsNkFpa8Fp34eMkzRNYilX6YAuRlS1PoRWl1nTmhrar4yS7OA0G51mR6fDwdWxu89rXfziPwYH4GYEfN_8V_YNsTeDdw</recordid><startdate>202401</startdate><enddate>202401</enddate><creator>Williamson, Aoife</creator><creator>Houston, Peter</creator><creator>Paterson, Jennifer</creator><creator>Chalmers, Anthony J</creator><creator>McLoone, Philip</creator><creator>Fullerton, Natasha</creator><creator>Foo, Sin Yee</creator><creator>James, Allan</creator><creator>Nowicki, Stefan</creator><general>Oxford University Press</general><scope>TOX</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><orcidid>https://orcid.org/0009-0007-7443-6658</orcidid></search><sort><creationdate>202401</creationdate><title>Dosimetric comparison of hippocampal-sparing technologies in patients with low-grade glioma</title><author>Williamson, Aoife ; Houston, Peter ; Paterson, Jennifer ; Chalmers, Anthony J ; McLoone, Philip ; Fullerton, Natasha ; Foo, Sin Yee ; James, Allan ; Nowicki, Stefan</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c254t-dfa04ab28356521d116968a3bf3d4064a62a7b719ec10018631fc2647eaf0a443</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Williamson, Aoife</creatorcontrib><creatorcontrib>Houston, Peter</creatorcontrib><creatorcontrib>Paterson, Jennifer</creatorcontrib><creatorcontrib>Chalmers, Anthony J</creatorcontrib><creatorcontrib>McLoone, Philip</creatorcontrib><creatorcontrib>Fullerton, Natasha</creatorcontrib><creatorcontrib>Foo, Sin Yee</creatorcontrib><creatorcontrib>James, Allan</creatorcontrib><creatorcontrib>Nowicki, Stefan</creatorcontrib><collection>Oxford Journals Open Access Collection</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Neuro-oncology advances</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Williamson, Aoife</au><au>Houston, Peter</au><au>Paterson, Jennifer</au><au>Chalmers, Anthony J</au><au>McLoone, Philip</au><au>Fullerton, Natasha</au><au>Foo, Sin Yee</au><au>James, Allan</au><au>Nowicki, Stefan</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Dosimetric comparison of hippocampal-sparing technologies in patients with low-grade glioma</atitle><jtitle>Neuro-oncology advances</jtitle><addtitle>Neurooncol Adv</addtitle><date>2024-01</date><risdate>2024</risdate><volume>6</volume><issue>1</issue><spage>vdae131</spage><pages>vdae131-</pages><issn>2632-2498</issn><eissn>2632-2498</eissn><abstract>Abstract Background Radiotherapy (RT) plays an integral role in the management of low-grade gliomas (LGG). Late toxicity from RT can cause progressive neurocognitive dysfunction. Radiation-induced damage to the hippocampus (HCP) plays a considerable role in memory decline. Advancements in photon planning software have resulted in the development of multi-criteria optimization (MCO) and HyperArc technologies which may improve HCP sparing while maintaining planning target volume (PTV) target coverage. Methods Three planning methods for hippocampal sparing (HS) were compared, volumetric modulated arc therapy (VMAT) without HS (VMAT_noHS), VMAT with HS (VMAT_HS), MCO with HS (MCO_HS), and HyperArc with HS (HyperArc_HS). Results Twenty-five patients were identified. The contralateral HCP was spared in 16 patients and bilateral HCP in 9 patients with superiorly located tumors. All 3 HS planning techniques showed significant reductions in dose to the spared HCP in contralateral cases but only VMAT_HS and MCO_HS achieved this in bilateral cases (P &lt; .008). Only MCO_HS was superior to VMAT_HS in lowering the dose to both contralateral HCP and bilateral HCP in all measured metrics (P &lt; .008). PTV and OAR (organ at risk) dose constraints were achieved for all plans. Conclusions This retrospective dosimetric study demonstrated the feasibility of HS for low-grade glioma. All 3 HS planning techniques achieved significant dose reductions to the spared contralateral hippocampus, but only MCO_HS and VMAT_HS achieved this in bilateral cases. MCO was superior to other planning techniques for sparing both bilateral and contralateral hippocampi.</abstract><cop>US</cop><pub>Oxford University Press</pub><pmid>39220244</pmid><doi>10.1093/noajnl/vdae131</doi><orcidid>https://orcid.org/0009-0007-7443-6658</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 2632-2498
ispartof Neuro-oncology advances, 2024-01, Vol.6 (1), p.vdae131
issn 2632-2498
2632-2498
language eng
recordid cdi_proquest_miscellaneous_3099856679
source DOAJ Directory of Open Access Journals; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; Oxford Journals Open Access Collection; PubMed Central
title Dosimetric comparison of hippocampal-sparing technologies in patients with low-grade glioma
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-05T03%3A29%3A26IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Dosimetric%20comparison%20of%20hippocampal-sparing%20technologies%20in%20patients%20with%20low-grade%20glioma&rft.jtitle=Neuro-oncology%20advances&rft.au=Williamson,%20Aoife&rft.date=2024-01&rft.volume=6&rft.issue=1&rft.spage=vdae131&rft.pages=vdae131-&rft.issn=2632-2498&rft.eissn=2632-2498&rft_id=info:doi/10.1093/noajnl/vdae131&rft_dat=%3Cproquest_cross%3E3099856679%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=3099856679&rft_id=info:pmid/39220244&rft_oup_id=10.1093/noajnl/vdae131&rfr_iscdi=true